共 39 条
[31]
Mackworth-Young C., Antiphospholipid antibodies: more than just a disease marker?, Immunol Today, 11, pp. 60-65, (1990)
[32]
Smeenk R.J.T., Lucassen W.A.M., Swaak T.J., Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity?, Arthritis Rheum, 30, pp. 607-617, (1987)
[33]
Rauch J., Tannenbaum H., Stollar B.D., Schwartz R.S., Monoclonal anticardiolipin antibodies bind to DNA, Eur J Immunol, 14, pp. 529-534, (1984)
[34]
Eilat D., Zlotnick A.Y., Fischel R., Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE experimental animals, Clin Exp Immunol, 65, pp. 269-278, (1986)
[35]
Harris E.N., Gharavi A.E., Loizou S., Derue G., Chan J.K., Patel B.M., Mackworth-Young C.G., Bunn C.C., Hughes G.R.V., Crossreactivity of antiphospholipid antibodies, J Clin Lab Immunol, 16, pp. 1-6, (1985)
[36]
Ishii Y., Nagasawa K., Mayumi T., Niho Y., Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus, Ann Rheum Dis, 49, pp. 387-390, (1990)
[37]
Branch D.W., Scott J.R., Kochenour N.K., Heashgold E., Obstetric complications associated with the lupus anticoagulant, N Engl J Med, 313, pp. 1322-1326, (1985)
[38]
Gatenby P.A., Cameron K., Shearman R.P., Pregnancy loss with anticardiolipin antibodies. Improved outcome with aspirin containing treatment, Aust N Z J Obstet Gynaecol, 29, pp. 294-298, (1989)
[39]
Rosove M.H., Tabsh K., Howard P., Wasserstrum N., Brinkman C.R., Heparin therapy for prevention of fetal wastage in women with anticardiolipin antibodies and lupus anticoagulants (abstract), Blood, 70, (1987)